JeanThierryBarbeyMD

PubMed

• 7 citations
  Man versus Machine: Comparison of Automated and Manual Methodologies for Measuring the QTc Interval: A Prospective Study.
  Jean T. Barbey, Margaret Connolly, Brenda Beaty, Mori J. Krantz> ;Annals of Noninvasive Electrocardiology. 2016 Jan 1
• Vardenafil-Associated QTc Changes: Not Merely a Normal Autonomic Process.
  Barbey, J. T.> ;Clin Pharmacol Ther. 2012 Apr
• 31 citations
  Factors influencing QT prolongation in patients hospitalized with severe anorexia nervosa.
  Mori J. Krantz, Allison L. Sabel, Utpal N Sagar, Carlin S. Long, Jean T. Barbey, Kenneth V. White, Jennifer L. Gaudiani, Philip S. Mehler> ;General Hospital Psychiatry. 2012 Mar 1
• 15 citations
  The impact of posture on cardiac repolarization: more than heart rate?
  Gregory C. Williams, Katherine M. Dunnington, Ming-yi Hu, Thomas R. Zimmerman, Zhiming Wang, Kerry B. Hafner, Maxine Stoltz, Edward K. Hill, Jean T. Barbey> ;Journal of Cardiovascular Electrophysiology. 2006 Apr 1
• 164 citations
  Effect of Arsenic Trioxide on QT Interval in Patients With Advanced Malignancies
  Jean T. Barbey, John C. Pezzullo, Steven L. Soignet> ;Journal of Clinical Oncology. 2003 Oct 1
• 56 citations
  Spontaneous Adverse Event Reports of Serious Ventricular Arrhythmias, QT Prolongation, Syncope, and Sudden Death in Patients Treated with Cisapride:
  Jean T. Barbey, Ralph Lazzara, Douglas P. Zipes> ;Journal of Cardiovascular Pharmacology and Therapeutics. 2002 Jun 1
• 2 citations
  Loratadine/nefazodone interaction.
  Jean T. Barbey> ;Clinical Pharmacology and Therapeutics. 2002 May 1
• 43 citations
  Prolongation of the QT Interval and Ventricular Tachycardia in Patients Treated with Arsenic Trioxide for Acute Promyelocytic Leukemia
  Jean T. Barbey, Steven Soignet> ;Annals of Internal Medicine. 2001 Nov 6
• 17 citations
  Cardiac toxicity of arsenic trioxide
  Jean T. Barbey> ;Blood. 2001 Sep 1
• 35 citations
  Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation.
  Darrell R. Abernethy, Jean T. Barbey, John Franc, Karen S. Brown, Irene Feirrera, Neville Ford, Daniel E. Salazar> ;Clinical Pharmacology and Therapeutics. 2001 Mar 1
• 31 citations
  Pharmacokinetics and pharmacodynamics of sotalol in a pediatric population with supraventricular and ventricular tachyarrhythmia.
  J. Philip Saul, Bertrand A. Ross, Michael Schaffer, Lee B. Beerman, Armen P. Melikian, Jun Shi, John Williams, Jean T. Barbey, Judy Jin, Peter H. Hinderling> ;Clinical Pharmacology and Therapeutics. 2001 Mar 1
• 24 citations
  Stereoselective halofantrine disposition and effect: concentration-related QTc prolongation.
  Darrell R. Abernethy, David L. Wesche, Jean T. Barbey, Colin Ohrt, Sarina Mohanty, John C. Pezzullo, Brian G. Schuster> ;British Journal of Clinical Pharmacology. 2001 Mar 1
• 22 citations
  Pharmacokinetic, pharmacodynamic, and safety evaluation of an accelerated dose titration regimen of sotalol in healthy middle-aged subjects
  Jean T. Barbey, Mark E. Sale, Raymond L. Woosley, Jun Shi, Armen P. Melikian, Peter H. Hinderling> ;Clinical Pharmacology and Therapeutics. 1999 Jul 1
• 24 citations
  Cardiovascular safety of second-generation antihistamines.
  Jean T. Barbey, Mark Anderson, Giorgio Ciprandi, Anthony J. Frew, Martin Morad, Silvia G. Priori, Ennio Ongini, Melton B. Affrime> ;American Journal of Rhinology. 1999 May 1
• 3 citations
  Adenosine A1‐receptor occupancy predicts A1‐receptor antagonist effects of N‐0861
  Sally Usdin Yasuda, Satoru Nagashima, Erwin Douyon, Robert E. Benton, Raymond L. Woosley, Jean T. Barbey> ;Clinical Pharmacology and Therapeutics. 1998 Nov 1
• 170 citations
  SSRI Safety in Overdose
  Jean T. Barbey, Steven P. Roose> ;The Journal of Clinical Psychiatry. 1998 Jul 1
• 5 citations
  Alterations in heart rate following radiofrequency ablation in the treatment of reentrant supraventricular arrhythmias: relation to alterations in autonomic tone
  Ralph J. Verdino, Cynthia M. Tracy, Allen J. Solomon, Mark Sale, Jean T. Barbey> ;Journal of Interventional Cardiac Electrophysiology. 1997 Sep 1
• 2 citations
  VASODEPRESSOR SYNCOPE: Diagnosis and Management
  Jean T. Barbey> ;Cardiology Clinics. 1997 May 1
• 1 citations
  Loading Dose of Digoxin
  Jean T. Barbey, Stephen R. Donahue> ;JAMA. 1997 Feb 19
• 22 citations
  Chlorpheniramine plasma concentration and histamine H1‐receptor occupancy
  Sally Usdin Yasuda, Anton Wellstein, Paul Likhari, Jean T. Barbey, Raymond L. Woosley> ;Clinical Pharmacology and Therapeutics. 1995 Aug 1
• 49 citations
  The electrocardiographic effects of cetirizine in normal subjects
  Mark E. Sale, Jean T. Barbey, Raymond L. Woosley, Dearborn Edwards, Jen Yeh, Kamlesh Thakker, Menger Chung> ;Clinical Pharmacology and Therapeutics. 1994 Sep 1
• 11 citations
  d-Sotalol reduces heart rate in vivo through a β-adrenergic receptor-independent mechanism
  Sally Usdin Yasuda, Jean T. Barbey, Christian Funck-Brentano, Anton Wellstein, Raymond L. Woosley> ;Clinical Pharmacology and Therapeutics. 1993 Apr 1
• 1 citations
  A Simple In Vivo Model to Evaluate the Effects of Antiarrhythmic Agents
  Allen J. Solomon, David Syn, Jean T. Barbey> ;Pacing and Clinical Electrophysiology. 1992 Nov 1
• 7 citations
  Clinical pharmacology and beta-blocking efficacy of propafenone.
  Jean T. Barbey> ;Journal of Cardiovascular Pharmacology. 1991 Jan 1
• 25 citations
  Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockade.
  Katherine T. Murray, C. S. Reilly, Richard P. Koshakji, Dan M. Roden, Mark D. Lineberry, Alastair J. J. Wood, Lyle A. Siddoway, Jean T. Barbey, Raymond L. Woosley> ;The Journal of Clinical Investigation. 1990 Mar 1
• Join now to see all

Journal Articles

• Factors Influencing QT Prolongation in Patients Hospitalized with Severe Anorexia Nervosa  
  Krantz M J, Sabel A L Sagar U, Long C S, Barbey JT, White KV, Gaudiani J L, and Mehler P S, General Hospital Psychiatry, 1/1/2012
• A Prospective, Single-blind, Placebo-controlled, Randomized, Crossover Study to Assess the Performance of Automated and Manual Methodologies for Detecting QTCc Interva...  
  Ruff D, Connolly M, Brueckner R, Bynum L, Beck D, Gussak I, Barbey J T, White K, Krantz M J, Affrime JM, Clin Pharmacol Ther, 1/1/2011
• Man Vs Machine: Are Cardiac Core Labs Still Relevant?  
  Barbey JT, Pezzullo JC, White K, Affrime M, J Clin Pharmacol, 1/1/2011
• The Impact of Posture on Cardiac Repolarization: More than Heart Rate?  
  Williams G, Dunnington K, Ming-Yi H, Zimmerman T, Zhiming W, Hafner K, Stolz M, Hill E and Barbey JT, J Cardiovasc Electrophysiology, 1/1/2006
• Spontaneous Adverse Event Reports of Serious Ventricular Arrhythmias, QT Prolongation, Syncope, and Sudden Death in Patients Treated with Cisapride  
  Barbey JT, Lazzara R, Zipes D, J Cardiovasc Pharmacol Therapeut, 1/1/2002
• Stereoselective Halofantrine Disposition and Effect: Concentration-related QTc Prolongation  
  Abernethy DR, Wesche DL, Barbey JT, Orth C, Mohanty S, Pezzullo JC and Schuster BG, Br J Clin Pharm, 1/1/2001
• Drug-induced Torsade De Pointes: The Perspectives of Industry  
  Barbey JT, Eur Heart J, 1/1/2001
• Determination of QT Response Phenotype with Low-dose Ibutilide  
  Kilborn MJ, Liu XK, Rodriguez I, Barbey JT, Woosley RL, Circulation, 1/1/2000
• Arsenic Trioxide (ATO): Analysis of QT Prolongation on Electrocardiogram (ECG)  
  Barbey JT, Soignet SL, Blood, 1/1/2000
• Beta-receptor Occupancy after Chronic Bisoprolol Dosing  
  Rosebraugh CJ, Barbey JT, Funck-Brentano C, Yasuda SU, Clin Pharmacol Ther, 1/1/1999
• Halofantrine Stereoselective Clearance and QT Prolongation  
  Abernethy DR, Wesche D, Barbey JT, Orth C, Mohanty S, Pezzullo J, Schuster, Clin Pharmacol Ther, 1/1/1999
• Review of Spontaneous Adverse Reports and Serious Ventricular Arrhythmias, QT Prolongation, Syncope and Sudden Death in Patients Treated with Cisapride  
  Zipes DP, Barbey JT and Lazzara R, Circulation, 1/1/1999
• Pharmacokinetic, Pharmacodynamic and Safety Evaluation of an Accelerated Dose Titration Regimen of Sotalol in Healthy Middle-aged Subjects  
  Barbey JT, Sale ME, Woosley RL, Shi J, Melikian AP, and Hinderling PH, Clin Pharmacol Ther, 1/1/1999
• Cardiovascular Safety of Second-generation Antihistamines  
  Barbey JT, Anderson M, Ciprandi G, Freu AJ, Morad M, Priori SG, Ongini E and Affrime MB, J of Rhinology, 1/1/1999
• Computer Analysis of ECG Repolarization  
  Sale M, Barbey JT and Woosley RL, Clin Pharmacol Ther, 1/1/1998
• Variations in the Drug-Induced QT Interval Prolongation during the Menstrual Cycle and Comparison to Males  
  Rodriguez I, Barbey JT and Woosley RL, Circulation, 1/1/1998
• Adenosine A1-receptor Antagonist Effects of N-0861  
  Yasuda SU, Nagashima S, Douyon E, Benton RE, Woosley RL and Barbey JT, Clin Pharmacol Ther, 1/1/1998
• Loading Dose of Digoxin Questions and Answers  
  Barbey JT and Donahue SR, JAMA, 1/1/1997
• Accuracy of Computerized ECG Analysis of Drug-induced QT Prolongation  
  Woosley RL, Benton RE, Barbey JT, Sale M, Clin Pharmacol Ther, 1/1/1997
• Alterations in Heart Rate following Radiofrequency Ablation in the Treatment of Reentrant Supraventricular Arrhythmias: Relation to Alterations in Autonomic Tone  
  Verdino RJ, Tracy CT, Solomon AJ, Sale ME, Barbey JT, Journal of Interventional Cardiac Electrophysiology, 1/1/1997
• Heart Rate Variability as a Measure of Autonomic Function in Patients with Fibromyalgia (FM) And Chronic Fatigue Syndrome (CFS)  
  Clauw DJ, Radulovic D, Heshmat Y, and Barbey JT, Arthritis Rheum, 6/1/1995
• Tilt Table Testing as a Measure of Dysautonomia in Fibromyalgia  
  Radulovic D, Barbey JT, Katz P, Baraniuk JN, and Clauw DJ, Arthritis Rheum, 6/1/1995
• Potential Limitations of AM Holter Monitoring for Tracking Electrical Instability by T Wave Alternans Analysis  
  Nearing BD, Barbey JT, Verrier RL, PACE, 1/1/1995
• Chlorpheniramine Plasma Concentration and Histamine H1-receptor Occupancy  
  Yasuda SU, Wellstein A, Likhari P, Barbey JT, Woosley R, Clin Pharm and Ther, 1/1/1995
• Antihistamines: Cardiovascular Effects  
  Barbey JT, Antihistamine Update Symposium Proceeding, Hospital Medicine, 1/1/1995
• Join now to see all

Books/Book Chapters

• Cardiac Electrophysiology Review 
  Chapter: Drugs for the Prevention and Control of Syncope 
  Page 316 - 319Barbey JTKluwer Academic Publishers2000
• Syncope Cardiology Clinics 
  Chapter: Vasodepressor Syncope 
  Barbey JTEditors: Klein G.WB Saunders1997
• Coronary Care 
  Chapter: Treatment of Ventricular Arrhythmias in Acute Myocardial Infarction 
  Woosley RL, Barbey JTEditors: Francis G.Little and BrownEdition 2nd,1995
• Coronary Care for the House Officer 
  Chapter: Cardiovascular Drug Pharmacology 
  Page 233 - 249Barbey JTEditors: Rich MW.William and Wilkins, Baltimore1989
• Join now to see all

Lectures

• Combining ECG, Biomarkers and Cardiac Imaging for Enhanced Patient Safety during Clinical Trials 
  7/1/2005
• Learning from Adverse Events 
  9/1/2003
• QT Prolongation by Non-cardiac Drugs 
  Howard University - 1/1/2003
• Out-patient Use of Antiarrhythmic Drugs: Initiation, Monitoring and NIPS 
  5/1/2001
• Acquired Long QT Syndrome as an Avoidable Drug Reaction 
  4/1/2001
• The Acquired Long QT Syndrome: The Clinical Perspective 
  3/1/2001
• Acquired Long QT Syndrome as a Pathognomonic Adverse Drug Reaction 
  9/1/2000
• Autonomically Mediated Mechanisms of Syncope 
  11/1/1999
• QT Prolongation: The Perspective of the Industry 
  6/1/1999
• Clinical Pharmacokinetics for the Electrophysiologist 
  5/1/1999
• Use and Abuse of Upright Tilt Testing in Patients with Unexplained Syncope 
  5/1/1998
• Join now to see all